NIH-funded research R21 grant

Improving organ transplant success by protecting blood vessel cells from injury

Official title: Ex vivo maintenance of endothelial cell barrier integrity via gap junction modification to prevent early ischemic injury in solid organ transplantation

Funded at Northwestern University at Chicago · NIH-10890184 · Data updated 2026-11-12

This study is looking at ways to help the cells that line blood vessels in transplanted organs stay healthy, so that patients can have better chances of their new organs working well and lasting longer.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionNorthwestern University at Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startJuly 18, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$197,143
NIH project number5R21AI173763-02
Project IDNIH-10890184 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals undergoing organ transplantation, particularly those receiving solid organ grafts.

Less likely to help

Patients who are not candidates for organ transplantation or those with advanced organ failure may not benefit from this research.

What this research studies

This research investigates how to maintain the integrity of endothelial cells, which line blood vessels, during organ transplantation. It focuses on preventing early injuries that can occur when donor organs are preserved and then reconnected to the recipient's blood supply. By modifying gap junctions in these cells, the study aims to enhance their ability to communicate and form a protective barrier, potentially leading to better outcomes for transplanted organs. Patients may benefit from improved graft survival and reduced risk of organ failure.

Why it matters

Potential benefit: If successful, this research could lead to higher success rates in organ transplants and longer-lasting grafts.

How similar studies have gone: Previous research has shown promise in enhancing graft survival through similar approaches, indicating potential for success in this area.

Where this research is happening

  • Northwestern University at Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Nadig, Satish N — Northwestern University at Chicago
  • Study coordinator: Nadig, Satish N

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.